Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00100256
Recruitment Status : Unknown
Verified January 2019 by Andarix Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : December 28, 2004
Last Update Posted : January 10, 2019
Information provided by (Responsible Party):
Andarix Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Unknown
Primary Completion Date : June 2004
Estimated Study Completion Date : April 2020